Discover a medication employed in the treatment of Ménière’s disease, an inner-ear disorder. Betahistine is utilized to alleviate the frequency and intensity of the distinct episodes of nausea and vertigo associated with this condition. By targeting the underlying mechanisms of Ménière’s disease, betahistine works to reduce the severity of symptoms and improve the overall quality of life for individuals affected by this disorder. The use of betahistine exemplifies the advancements in medical management aimed at providing relief and enhancing the well-being of those living with Ménière’s disease.